Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.9M 25.1M 23.31M 21.5M 40.5M 41.23M 276M 108M 1.37B 109M 106M 4.61B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.11M 26.15M 24.29M 22.4M 42.19M 42.96M 288M 113M 1.43B 113M 111M 4.8B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+3.10%
1 week+5.15%
Current month-4.92%
1 month-4.92%
3 months+36.13%
6 months+6.28%
Current year-2.61%
1 week 76.95
Extreme 76.95
85.85
1 month 76.95
Extreme 76.95
89.97
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 24
Extreme 24
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member 55 18/08/2023
Director/Board Member 62 -
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+3.10%+5.15%-6.05%+198.87% 37.54M
-1.26%-5.15%+53.28%+149.57% 1,030B
+0.77%-2.71%+55.55%+52.96% 617B
-1.68%-2.62%+33.62%+68.85% 455B
+0.24%-0.37%+37.61%+30.75% 350B
-0.11%-0.41%+34.18%+38.77% 299B
-0.49%-0.19%+11.67%+13.05% 265B
-7.37%-4.40%-2.54%-43.87% 225B
-1.30%+1.39%+29.20%+62.84% 209B
-0.79%+0.48%+15.71%+70.65% 163B
Average -0.85%+3.27%+26.22%+64.24% 361.27B
Weighted average by Cap. -0.99%+1.48%+38.47%+71.58%

Financials

2024 2025
Net sales 237M 2.48M 2.15M 2M 1.84M 3.47M 3.54M 23.67M 9.27M 118M 9.31M 9.1M 395M 637M 6.67M 5.79M 5.38M 4.96M 9.34M 9.51M 63.67M 24.93M 316M 25.04M 24.49M 1.06B
Net income 7.85M 82.19K 71.39K 66.3K 61.14K 115K 117K 785K 307K 3.9M 309K 302K 13.11M 89.25M 935K 812K 754K 695K 1.31M 1.33M 8.93M 3.5M 44.33M 3.51M 3.43M 149M
Net Debt -57.64M -604K -524K -487K -449K -846K -861K -5.77M -2.26M -28.63M -2.27M -2.22M -96.28M 115M 1.21M 1.05M 975K 899K 1.69M 1.72M 11.54M 4.52M 57.3M 4.54M 4.44M 193M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
31/07/26 84.58 +3.10% 15,463
30/07/26 ₹82.04 -0.93% 12,629
29/07/26 ₹82.81 +7.25% 17,115
28/07/26 ₹77.21 -3.58% 9,732
27/07/26 ₹80.08 -2.99% 7,117
  1. Stock Market
  2. Stocks
  3. MACINTR Stock